Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Feb 14;15(2):537.
doi: 10.3390/v15020537.

Risk Factors for Influenza-Induced Exacerbations and Mortality in Non-Cystic Fibrosis Bronchiectasis

Hung-Yu Huang  1   2   3 , Chun-Yu Lo  1   2 , Fu-Tsai Chung  1   2   3 , Yu-Tung Huang  4 , Po-Chuan Ko  4 , Chang-Wei Lin  1   2 , Yu-Chen Huang  1   2 , Kian Fan Chung  5   6 , Chun-Hua Wang  1   2
Affiliations

Risk Factors for Influenza-Induced Exacerbations and Mortality in Non-Cystic Fibrosis Bronchiectasis

Hung-Yu Huang et al. Viruses. .

Abstract

Influenza infection is a cause of exacerbations in patients with chronic pulmonary diseases. The aim of this study was to investigate the clinical outcomes and identify risk factors associated with hospitalization and mortality following influenza infection in adult patients with bronchiectasis. Using the Chang Gung Research Database, we identified patients with bronchiectasis and influenza-related infection (ICD-9-CM 487 and anti-viral medicine) between 2008 and 2017. The main outcomes were influenza-related hospitalization and in-hospital mortality rate. Eight hundred sixty-five patients with bronchiectasis and influenza infection were identified. Five hundred thirty-six (62%) patients with bronchiectasis were hospitalized for influenza-related infection and 118 (22%) patients had respiratory failure. Compared to the group only seen in clinic, the hospitalization group was older, with more male patients, a lower FEV1, higher bronchiectasis aetiology comorbidity index (BACI), and more acute exacerbations in the previous year. Co-infections were evident in 55.6% of hospitalized patients, mainly caused by Pseudomonas aeruginosa (15%), fungus (7%), and Klebsiella pneumoniae (6%). The respiratory failure group developed acute kidney injury (36% vs. 16%; p < 0.001), and shock (47% vs. 6%; p < 0.001) more often than influenza patients without respiratory failure. The overall mortality rate was 10.8% and the respiratory failure group exhibited significantly higher in-hospital mortality rates (27.1% vs. 6.2%; p < 0.001). Age, BACI, and previous exacerbations were independently associated with influenza-related hospitalization. Age, presence of shock, and low platelet counts were associated with increased hospital mortality. Influenza virus caused severe exacerbation in bronchiectasis, especially in those who were older and who had high BACI scores and previous exacerbations. A high risk of respiratory failure and mortality were observed in influenza-related hospitalization in bronchiectasis. We highlight the importance of preventing or treating influenza infection in bronchiectasis.

Keywords: acute exacerbations; bacteria; bronchiectasis; co-infection; influenza.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Flow diagram. CGRD: Chang Gung Research Database.
Figure 2
Figure 2
Annual incident numbers of bronchiectasis with influenza infection in CGRD since 2008–2017. CGRD: Chang Gung Research Database.
See this image and copyright information in PMC

References

    1. Cole P.J. Inflammation: A two-edged sword--the model of bronchiectasis. Eur. J. Respir. Dis. Suppl. 1986;147:6–15. - PubMed
    1. Hill A.T., Haworth C.S., Aliberti S., Barker A., Blasi F., Boersma W., Chalmers J.D., De Soyza A., Dimakou K., Elborn J.S., et al. Pulmonary exacerbation in adults with bronchiectasis: A consensus definition for clinical research. Eur. Respir. J. 2017;49:1700051. doi: 10.1183/13993003.00051-2017. - DOI - PubMed
    1. Chalmers J.D., Aliberti S., Filonenko A., Shteinberg M., Goeminne P.C., Hill A.T., Fardon T.C., Obradovic D., Gerlinger C., Sotgiu G., et al. Characterization of the “frequent exacerbator phenotype” in bronchiectasis. Am. J. Respir. Crit. Care Med. 2018;197:1410–1420. doi: 10.1164/rccm.201711-2202OC. - DOI - PubMed
    1. Chalmers J.D., Goeminne P., Aliberti S., McDonnell M.J., Lonni S., Davidson J., Poppelwell L., Salih W., Pesci A., Dupont L.J., et al. The bronchiectasis severity index. An international derivation and validation study. Am. J. Respir. Crit. Care Med. 2014;189:576–585. doi: 10.1164/rccm.201309-1575OC. - DOI - PMC - PubMed
    1. Richardson H., Dicker A.J., Barclay H., Chalmers J.D. The microbiome in bronchiectasis. Eur. Respir. Rev. 2019;28:190048. doi: 10.1183/16000617.0048-2019. - DOI - PMC - PubMed

Publication types